A RASSF1A 133 single-nucleotide polymorphism is associated with increased susceptibility and unfavorable prognosis in non-small cell lung cancer | |
Wang, An; Hou, Likun; Huang, Dayu; Zhang, Huijun; Wang, Shaohua; Geng, Xin; Tan, Yu-Long; Wu, Chunyan; Chen, Xiaofeng | |
刊名 | INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
![]() |
2017 | |
卷号 | 10期号:7 |
关键词 | RASSF1A SNP prognosis tumor-suppressor gene (TSG) NSCLC EGFR mutation |
ISSN号 | 1940-5901 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3618428 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Wang, An,Hou, Likun,Huang, Dayu,et al. A RASSF1A 133 single-nucleotide polymorphism is associated with increased susceptibility and unfavorable prognosis in non-small cell lung cancer[J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE,2017,10(7). |
APA | Wang, An.,Hou, Likun.,Huang, Dayu.,Zhang, Huijun.,Wang, Shaohua.,...&Chen, Xiaofeng.(2017).A RASSF1A 133 single-nucleotide polymorphism is associated with increased susceptibility and unfavorable prognosis in non-small cell lung cancer.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE,10(7). |
MLA | Wang, An,et al."A RASSF1A 133 single-nucleotide polymorphism is associated with increased susceptibility and unfavorable prognosis in non-small cell lung cancer".INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE 10.7(2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论